Thiazolidinediones may increase risk of heart failure

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1599, 2007-01, pp. : 17-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thiazolidinediones increase risk of heart failure

Inpharma, Vol. 1, Iss. 1418, 2003-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Thiazolidinediones may double the risk of heart failure (HF) among patients receiving such drugs for type 2 diabetes mellitus

Reactions Weekly, Vol. 1, Iss. 1162, 2007-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Heart failure warnings for thiazolidinediones

Inpharma, Vol. 1, Iss. 1316, 2001-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Rosiglitazone may increase the risk of chronic heart failure (HF) in patients receiving insulin for type 2 diabetes mellitus

Reactions Weekly, Vol. 1, Iss. 1030, 2004-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

No increase in HF risk or mortality with thiazolidinediones

Reactions Weekly, Vol. 1, Iss. 1160, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite